Navigation Links
Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
Date:2/15/2011

MISSISSAUGA, Ontario, Feb. 15, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, February 24, 2011 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2010 fourth quarter and full year.

The dial-in number to participate on this call is (877) 295-5743, confirmation code 41335702.  International callers should dial (973) 200-3961, confirmation code 41335702. A replay will be available approximately two hours following the conclusion of the conference call to Thursday, March 3, 2011, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 41335702.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.Contact Information:Laurie W. Little 949-461-6002laurie.little@valeant.com(Logo:  

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Array BioPharma ... results for the fourth quarter and full ... conference call to discuss those results on ... Executive Officer and Michael Carruthers , ... Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern ...
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2
... a good night,s sleep to overall health have long been ... gender and weight management play in overall sleep patterns.  The ... Sleep and BMI , was presented during a poster session ... week. (Photo: http://photos.prnewswire.com/prnh/20111004/NE78562 ) ...
... YORK, Oct. 4, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0177915/US-Market-for-Neurological-Devices-2010.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment In 2009, ... valued at just over $2.2 billion, an ...
Cached Medicine Technology:Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3U.S. Market for Neurological Devices 2010 2U.S. Market for Neurological Devices 2010 3U.S. Market for Neurological Devices 2010 4U.S. Market for Neurological Devices 2010 5U.S. Market for Neurological Devices 2010 6U.S. Market for Neurological Devices 2010 7U.S. Market for Neurological Devices 2010 8U.S. Market for Neurological Devices 2010 9U.S. Market for Neurological Devices 2010 10U.S. Market for Neurological Devices 2010 11U.S. Market for Neurological Devices 2010 12U.S. Market for Neurological Devices 2010 13U.S. Market for Neurological Devices 2010 14U.S. Market for Neurological Devices 2010 15U.S. Market for Neurological Devices 2010 16U.S. Market for Neurological Devices 2010 17
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... appear to have a slightly increased risk of potentially ... Swedish researchers report. Doctors have previously suspected that ... raised risk of deep vein thrombosis and pulmonary embolism, ... veins, the researchers noted in background information. This ...
(Date:7/28/2014)... 28, 2014 The Oneida Indian Nation ... incredible field of accompanying PGA TOUR players will be ... analyst Notah Begay III for the seventh annual Notah ... Stone Resort Casino ’s Atunyote® Golf Club on Wednesday, ... Woods, Jason Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera ...
(Date:7/28/2014)... mobile devices are on the cusp of revolutionizing health ... providing everything from cardiac measurements to sonograms. , While ... and control costs, several health law experts say in ... (NEJM) report that more oversight is needed by the ... confidence and safety. Out of some 100,000 mHealth apps ...
(Date:7/28/2014)... New York (PRWEB) July 28, 2014 ... edition of “Organic Living” on March 12th, a campaign ... an organic lifestyle. In partnership with industry leader ... over 100 Certified Organic teas, the campaign provides readers ... recent years that continues to propel the industry forward ...
(Date:7/28/2014)... July 28, 2014 Irresistible infants have met their ... of Comfort. The online gifting company specializes in homemade chicken noodle ... The New Baby package starts with home-from-the-hospital essentials every new parent ... 6 rolls , 6 cookies , ... The soup is ready to heat and eat upon delivery, so ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... oncologist and Craig Greven, Vitreoretinal surgeon, Wake Forest University ... with radiation therapy. Uveal malignant melanoma// is a rare ... people per year in the United States. It is ... seen in nonwhite races. The results of the study ...
... was first initiated in India to help overcome Vitamin ... in India, it now lags behind African and neighbouring ... report.,The report entitled "Controlling Vitamin and Mineral Deficiencies in ... the largest percentage as well as the largest absolute ...
... Alzheimer’s disease (AD), characterized by progressive memory loss, decline ... a major threat to ageing population.// ,A ... reviews the different strategies in drug discovery. Hong-Yu Zhang, ... of the present one-drug-one-target strategy in drug discovery is ...
... levels of low density lipoprotein (LDL) (also called bad ... are taking statins.// ,Those taking high doses of ... milligrams/deciliters to as low as 40 mg/dL. No one ... P. Cannon, a cardiologist at Brigham and Women's Hospital ...
... to a diverse range of insults, such as surgery, ... range of cell types of the immune system, creating ... inflammatory response, although essential for fighting infection, may damage ... mediators, cytokines and lipid mediators being the key mediators. ...
... Singh and Union Health Minister Anbumani Ramadoss are to convene ... problem of bird flu epidemic. //Awareness of bird flu and ... to the Western countries. The World Health Organization has sent ... if there are any possible flu attack. Dr. Anbumani said ...
Cached Medicine News:Health News:Radiation therapy effective against Eye cancer 2Health News:Vitamin A supplementation inadequate in India: Need for effective strategies 2Health News:The ideal composition of intravenous lipid emulsion 2
Triad Plus PVP-I Scrub Winged Sponges...
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Performance Panel consists of plasma specimens with ... for antibodies to the Hepatitis C Virus. ... manufacturers and diagnostic laboratories to evaluate their ... test systems are included for comparative analysis ...
Medicine Products: